🔥Telegram İfşa

Excited to start my independent career at Scripps Research. My lab will focus on the biosynthesis of complex (un)natural glycosides to advance vaccine development. We are hiring at all levels (postdocs, grad students, RAs). Find out more: liulabscripps.com

Want to make next-gen vaccine adjuvants using synthetic chemistry and biology? Apply to be a postdoctoral researcher in the Liu Lab at Scripps Research: recruiting2.ultipro.com/SCR1003TSRI/Jo…

Our work, led by former postdoc Yuzhong Liu and Professor Jay Keasling, on the complete biosynthesis of QS-21 in engineered yeast is out now in nature. We report the sustainable supply chain of an essential adjuvant for global immunization here: nature.com/articles/s4158…

My postdoc work on making the potent vaccine adjuvant QS-21 in yeast is online! Thanks to my coauthors and all of your support! Keasling Lab 🏳️‍🌈🏳️‍⚧️ Anne Osbourn College of Chemistry Berkeley Lab In my lab Scripps Research we're making next-gen adjuvants using synthetic biology. Stay tuned!

Prof. Yuzhong Liu is pioneering a sustainable method to produce QS-21, a highly sought-after molecule that improves vaccine effectiveness in yeast. This innovative approach reduces environmental impact and makes vaccines more accessible. Read the full Q+A: ow.ly/Blw150Snzc3

Super honored and thrilled to receive the Michelson Prize: Next Generation Grant! Thank you #MichelsonPrizes for the support as we work hard toward developing better and safer vaccine adjuvants. I'm grateful for this opportunity, and very excited for the journey ahead!